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Abstract: Several studies suggest that the plasma membrane is composed of micro-domains of 
saturated lipids that segregate together to form lipid rafts. Lipid rafts have been operationally defined 
as cholesterol- and sphingolipid-enriched membrane micro-domains resistant to solubilisation by non-
ionic detergents at low temperatures. Here we report a biophysical approach aimed at investigating 
lipid rafts of MDA-MB-231 human breast cancer cells by coupling an Atomic Force Microscopy (AFM) 
study to biochemical assays namely Western Blotting and High Performance Thin Layer 
Chromatography. Lipid rafts were purified by ultracentrifugation on discontinuous sucrose gradient 
using extraction with Triton X-100. Biochemical analyses proved that the fractions isolated at the 5% 
and 30% sucrose interface (fractions 5 and 6) have an higher content of cholesterol, sphingomyelin 
and flotillin-1 with respect to the other purified fractions. Tapping mode AFM imaging of fraction 5 
showed membrane patches whose height corresponds to the one awaited for a single lipid bilayer as 
well as the presence of micro-domains with lateral dimensions in the order of a few hundreds of 
nanometers. In addition, an AFM study using specific antibodies suggests the presence, in these micro-
domains, of a characteristic marker of lipid rafts, the protein flotillin-1. 
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quantitative analyses in order to improve the quality of the results and better clarify the applied 
methodologies.  
In particular, the new version includes:  
- the root-mean-square (rms) surface roughness analysis of membrane patches as well as of 
membrane micro-domains to quantify their surface corrugation. 
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physisorption phenomena we used as control experiment a non specific antibody (anti clathrin HC 
monoclonal antibody) raised against a non raft protein marker. New AFM topography images as 
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micro-domains before and after the antibody treatment.  
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Finally, we extensively revised the paper taking into account all the objections and the suggestions 
expressed by the two referees, to whom we would like to express our warmest thanks for their 
contribution. We therefore hope that the resulting substantially new paper we are sending you, 
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Note on the referees’comments 
 
 
 
 
Referee 1 Comments: 
 
1) page 2: The "hypothesis" of the existence of rafts is not that recent (1997). 
We thank the referee and we have modified the text (Introduction) in the revised manuscript 
accordingly. 
 
2) page 2: I don't think that monitoring the motion or the partitioning of fluorescence probes are 
DIRECT evidence for the existence of rafts. 
As suggested by the referee, we removed this sentence in the revised manuscript.   
 
3) page 2: "...of a few hundreds nanometers...". I think that the current view of the raft domains 
evidence raft size of ten to tens of nanometer in size. 
We removed the sentence in the revised manuscript. 
 
4) page 2: Transmission Electron Microscopy cannot assess raft structure. This has nothing to do 
with resolution. It is due to the fact that density differences are "probed" by the electrons, and 
therefore specific lipids have almost no contrast compared to other lipids or (flat) membrane 
proteins. On the other hand, the novel high-resolution optical microscopy techniques are powerful 
in the field. PALM/STORM/STED. The authors seem neglecting these aspects. 
We agree with the referee comment and changed the sentence at pag 2 (Introduction) in the revised 
manuscript adding, as suggested, considerations related to the application of novel super resolution 
optical microscopy techniques to the study of lipid rafts topic.   
 
5) page 3: "...kindly provided by Dr P Degan..." is not a reproducible Method. 
We thank the referee and we have modified the text (Materials and Methods) in the revised 
manuscript. 
 
6) page 6: The paragraph about AFM observing in aqueous environment is redundant from the 
introduction. 
We agree with the referee comment and removed the paragraph in the revised manuscript. 
 
7) page 6: Figure 4, Section analyses are missing 
As suggested by the referee, we performed the rms surface roughness analysis and the experimental 
data have been introduced in the revised manuscript (Results). 
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8) page 6, page 7, figures 3, 4, 5, 7: The problem is that the raft purification protocol using the 
Triton should result in the raft domains. As the author state, that this is basically how they are 
defined, membrane domains of nanometer size that are not solubilized during soft detergent 
treatment. Therefore the finding of membrane patches of 1-3µm in size is worrying and indicates 
that we are actually not looking at the "raft fraction". 
Classical preparation of  lipid rafts uses 1% Triton X-100 to extract whole cells and successive 
separation of the solubilised membranes on 5%-30% sucrose density gradient. Recently, different 
methods have been developed using a variety of other detergents or with detergent free techniques 
(Biophys J. 2011 Nov 16;101(10):2417-25. Measurement of lipid nanodomain (raft) formation and 
size in sphingomyelin/POPC/cholesterol vesicles shows TX-100 and transmembrane helices 
increase domain size by coalescing preexisting nanodomains but do not induce domain formation. 
Pathak P, London E). 
Some observations raised the hypothesis that extraction of cells with detergents may be generating 
clusters of raft lipids and proteins that did not exist in the intact cells. 
Our data showed in fraction 5 the presence of membrane patches of 1-3 µm that may be formed 
through a mechanism of coalescence as a result of detergent treatment. Nevertheless recent data 
demonstrated that  TX-100 does not induce domain formation or increase the fraction of the bilayer 
in the ordered state, although it does increase domain size by coalescing preexisting domains 
(Biophys J. 2011 Nov 16;101(10):2417-25. Measurement of lipid nanodomain (raft) formation and 
size in sphingomyelin/POPC/cholesterol vesicles shows TX-100 and transmembrane helices 
increase domain size by coalescing preexisting nanodomains but do not induce domain formation. 
Pathak P, London E). Thus our observations are in agreement with this theory. We added these 
considerations in the revised manuscript (Discussion and Conclusions). 
 
9) figure 4: The two domains labeled 3 are clearly different. One is flat and smooth and does 
clearly not contain potential proteins, the other is corrugated and fuzzy and does contain rough 
molecules. 
Really, the two microdomains labelled 3 in figure 4 exhibit a surface roughness as suggested by 
their corrugated appearance in AFM image (white spots). These microdomains are protruding from 
the  membrane lipid bilayer, labelled 2, which has a very smooth surface. In any case, we performed 
the rms surface roughness analysis of these regions and the experimental data have been introduced 
in the revised manuscript (Results). 
 
10) figure 5 and 6 (with respect to above comment): The domain in figure 5 is clearly different from 
domain shown in 6. The statement that there are proteins, appears as an overstatement.  
The different appearance of the two microdomains visualized in Fig. 5 and Fig. 6 is mainly related 
to the different dimensions of the scan areas and z range in the two figures. In particular, visualizing 
a smaller scan area the corrugated and fuzzy appearance of the microdomain surface appears to be 
better defined (Fig. 6; scan area = 200x200 nm
2
; vertical scale = 2 nm) than scanning a bigger area 
(Fig. 5; scan area = 1.6x1.6 μm2; vertical scale = 20 nm). Really, the microdomains exhibit a similar 
surface roughness as proved by the rms surface roughness analysis that has been introduced in the 
revised manuscript (Results). 
 
11) figure 7: There is a worrying region in the middle of the right panel. It appears like 
uncontrolled forces are applied. The "normal" lipid patch in the middle right of the image is about 
2 times larger in the right panel compared to the left. Antibody binding should result mainly in an 
increase of height and roughness of the domains (rather than enlargement), see antibody labeling 
of bacteriorhodopsin, 1996. 
Following the suggestion of the referee we performed the height profile analysis as well as the rms 
surface roughness analysis of the microdomains before and after the antibody treatment. Moreover, 
we repeated the antiboby experiment using as control experiment a non-specific antibody (anti 
clathrin hc, an antibody raised against a non raft protein marker) to get rid of possible physisorption 
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phenomena. New AFM topography images as well as experimental data obtained by the above 
described analyses have been introduced in the revised manuscript (Results). Moreover we would 
like to point out that in literature there are also works where the protein antibody labelling has been 
studied by AFM valuating the surface area increase (N Buzhynskyy, C Salesse and S Scheuring, 
Rhodopsin is spatially heterogeneously distributed in rod outer segment disk membranes, J. Mol. 
Recognit. 2011; 24: 483–489).  
 
 
 
Referee 2 Comments: 
 
1) The authors claim that AFM has the advantage of not requiring invasive sample preparation, at 
variance with EM, and other techniques. Nevertheless, the procedure followed for getting the 
various fractions to be studied by AFM exposes membranes to environments that are quite far from 
the physiologic one. The authors should comment on the impact of their sample preparation on the 
retrieval of physiologically revenant information about lidip rafts. 
We agree with the referee comment. In particular, we would like to point out that AFM requires 
sample preparation conditions less invasive in comparison to other microscopy techniques where 
staining, dehydration, and UHV are often needed. Nevertheless we are aware that the lipid raft 
purification protocol followed in the work exposes membranes to an environment quite far from the 
physiological one. We introduced these considerations in the revised manuscript (Discussion and 
Conclusions). 
 
2) Do the authors have a control over the membrane patch orientation at surface? This aspect is of 
course of main importance in assessing the presence of micro-domains by AFM. 
Really, the sample preparation protocol for AFM imaging we developed and used in the present 
work does not allow us to select the orientation of the membrane patches visualized on the mica 
support. We introduced this consideration in the revised manuscript and this point has been taken in 
account in the interpretation of the experimental data (Results; Discussion and Conclusions).  
 
3) i) How can the authors be sure that an AB suitable for WB can be used also in more native 
conditions on transmembrane proteins, since many domains (and the N-terminal domain of flotillin-
1 is not an exception) are membrane embedded? 
We agree with the referee comment. Unfortunately for a mistake we reported in the text an incorrect 
information. Really in the AB experiment we used a rabbit polyclonal AB raised against amino 
acids 324-427 of flot-1 (Santa Cruz Biotechnology), protein segment which is near its C-terminus 
and fully exposed in the cytoplasmic side of the plasma membrane. We changed the incorrect 
sentence in the revised manuscript (Results).  
 
4) ii) The authors define as "specific" the AB binding they get on their micro-domains, but they do 
not demonstrate any specificity. The control experiment without the AB is not informative in that 
sense. To demonstrate specificity, two more measurements should be performed i.e. a similar 
measurements with a non-specific AB, to get rid of possible physisorption phenomena; and an 
experiment with blockers (e.g peptides) which can compete with "specific" AB for binding the same 
epitope on flotillin-1. Otherwise, I think that any statement derived from experiments with AB and 
AFM has to be markedly weakened. 
As suggested by the referee we performed a new AB experiment. In particular, the anti flot-1 
experiment gave results fully comparable with the ones reported in the text. Moreover, to 
demonstrate specificity and get rid of possible physisorption phenomena we used as control 
experiment a non specific AB, the anti clathrin HC a mouse monoclonal antibody raised against the 
N-terminus of clathrin heavy chain (Santa Cruz Biotechnology) a non raft protein marker. New 
AFM topography images as well as experimental data have been introduced in the revised 
 4 
manuscript (Results). The suggested experiment using blockers is surely very relevant from the 
biochemical point of view but it appears not fully useful applying the AFM technique. In fact, AFM 
detects the antibody binding mainly as an enlargement of the microdomain surface area. Peptides 
could induce an increase of the microdomain surface area not easily noticeable from the effect 
produced by anti flot-1.     
 
5) pg. 3 "Tubes were centrifuged at 40000 rpm for 17 h at 4 °C in a Ultracentrifuge (Beckman 
Coulter)." The "g" equivalent must be provided (or the rotor diameter) in order to make the 
procedure repeatable. 
We thank the referee and we have modified the text in the revised manuscript accordingly. 
 
6) pg. 4 "Free CHOL and SM were quantified by HP-TLC with hexane/ether/glacial acetic acid 
(90:10:1 by volume) and with chloroform/methanol/glacial acetic acid/water (60:45:4:2 by 
volume)," Please, either use "/" or ":"  in the sentence. 
In the revised manuscript the text has been changed as suggested. 
 
 
 
 
 
 
 
 
 
 
 
 
Graphical Abstract (for review)
 Lipid rafts of MDA-MB-231 cancer cells were studied by AFM and biochemical assays. 
 
 AFM showed membrane micro-domains with lateral sizes of a few hundreds of nm. 
 
 WB and HP-TLC detected an high CHOL, SM and Flot-1 content in the micro-domains. 
 
 AFM study using specific antibodies identified Flot-1 in the micro-domains. 
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ABSTRACT 
 Several studies suggest that the plasma membrane is composed of micro-domains of 
saturated lipids that segregate together to form lipid rafts. Lipid rafts have been operationally 
defined as cholesterol- and sphingolipid-enriched membrane micro-domains resistant to 
solubilisation by non-ionic detergents at low temperatures. Here we report a biophysical approach 
aimed at investigating lipid rafts of MDA-MB-231 human breast cancer cells by coupling an 
Atomic Force Microscopy (AFM) study to biochemical assays namely Western Blotting and High 
Performance Thin Layer Chromatography. Lipid rafts were purified by ultracentrifugation on 
discontinuous sucrose gradient using extraction with Triton X-100. Biochemical analyses proved 
that the fractions isolated at the 5% and 30% sucrose interface (fractions 5 and 6) have an higher 
content of cholesterol, sphingomyelin and flotillin-1 with respect to the other purified fractions. 
Tapping mode AFM imaging of fraction 5 showed membrane patches whose height corresponds to 
the one awaited for a single lipid bilayer as well as the presence of micro-domains with lateral 
dimensions in the order of a few hundreds of nanometers. In addition, an AFM study using specific 
antibodies suggests the presence, in these micro-domains, of a characteristic marker of lipid rafts, 
the protein flotillin-1. 
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1. INTRODUTION  
 Accumulating evidence indicates that cell membrane constituents might be not randomly 
distributed but rather organized in small lipid/protein domains enriched in sphingomyelin (SM) and 
cholesterol (CHOL), known as lipid rafts [1, 2]. Lipid rafts are small, heterogeneous, highly 
dynamic, sterol- and sphingolipid-enriched domains resistant to solubilisation by non-ionic 
detergents (traditionally Triton X-100) at low temperatures [3]. Moreover, lipid rafts are enriched in 
GPI-anchored proteins [4] and also contain several signaling proteins, including for instance the 
epidermal growth factor receptor (EGFR) [5]. Proof of the existence of lipid rafts is based largely 
on biochemical evidence even if the lipid raft hypothesis is still a contentious topic, with much of 
the scientific community divided. In particular, the inability to visualize lipid rafts directly in cell 
membranes, as well as a lack of understanding of some basic properties (e.g. size and lifetime), has 
led to controversy over their definition and existence. 
To date, a large number of experimental results converge toward the idea that lateral domains 
enriched in SM and CHOL exist in native biological membranes. These micro-domains have been 
suggested to take part in various dynamic cellular processes such as membrane trafficking, signal 
transduction, and regulation of the activity of membrane proteins [1, 6, 7].  
In model membranes, the coexistence of domains in liquid ordered and liquid disordered phases is 
widely accepted [8, 9]. Self-associative properties unique to sphingolipids and CHOL in vitro could 
facilitate selective lateral segregation in the membrane plane and serve as a basis for lipid sorting in 
vivo [1].  
Studying lipid rafts is challenging since they are probably too small to be resolved by techniques 
such as optical and fluorescence microscopy. However, super resolution microscopy offers, in 
principle, the possibility to investigate samples with these size ranges. For example, stimulated-
emission-depletion (STED) nanoscopy (10) provided direct evidence in live cells that certain lipids 
are transiently trapped in CHOL-assisted molecular complexes (11, 12, 13). These studies revealed 
that the extent of the areas in which the lipids dwell during trapping is about 20 nm in diameter 
(11). Photoactivated localization microscopy (PALM) is another powerful approach for 
investigating protein/lipid organization. Combining pair-correlation analysis with PALM provided a 
method to analyze complex patterns of protein organization across the plasma membrane 
demonstrating a distinct nanoscale organization of plasma membrane proteins with different 
membrane anchoring and lipid partitioning characteristics in COS-7 cells as well as dramatic 
changes in GPI-anchored protein arrangement under varying perturbations (14). Moreover, PALM 
imaging proved that CHOL- and sphingolipid-enriched micro-domains occupy different regions on 
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the plasma membrane with lateral dimensions in the order of an hundred of nanometers (15). 
Atomic Force Microscopy (AFM), providing nanometer spatial resolution and operating in 
physiological-like conditions without fixation, staining, or labelling, appears to be an useful tool to 
quantitatively perform a morpho-dimensional characterization of lipid rafts as well as of their 
protein content [16]. Moreover, thanks to its high signal-to-noise ratio, AFM allows to monitor 
function related structural conformational changes and to observe structural details of membrane 
proteins under physiological conditions, revealing information on the protein oligomeric state and 
on the supramolecular architecture of membrane protein complexes [17-19]. 
 In this work we applied AFM, together with biochemical assays, namely Western Blotting 
(WB) and High Performance Thin Layer Chromatography (HP-TLC), to the study of lipid rafts of 
MDA-MB-231 human breast cancer cells. In particular, the different fractions, isolated in the 
purification process by ultracentrifugation on sucrose gradient, have been analysed with respect to 
their lipid content and morpho-dimensionally characterized. Interestingly, AFM imaging of the 
purified fractions with the richest CHOL and SM content, showed membrane micro-domains with 
lateral dimensions of a few hundreds of nanometers. Moreover, treating the samples with a specific 
antibody against the protein flotillin-1, an increase of the micro-domain surface area occurs thus 
suggesting the presence of flotillin-1, a lipid raft-associated protein [20], in the visualized 
membrane micro-domains.  
 
2. MATERIALS AND METHODS 
2.1 Cell line and culture conditions 
 Human breast cancer cell line MDA-MB-231 (ER-negative and over-expressing EGFR), 
derived from human mammary adenocarcinoma, were obtained from Italian National Cancer 
Research Institute cell bank. The MDA-MB-231 cell line was maintained in DMEM medium 
(Gibco-BRL, Life Technologies Italia srl, Italy) supplemented with 10% fetal bovine serum (FBS), 
100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM glutamine. Cells were grown at 37 °C in a 
5% CO2 atmosphere with 98% relative humidity. 
 
2.2 Lipid raft isolation 
 Cells were seeded at 1.5 x 10
4
 cells/cm
2
 in DMEM medium. After 48 h, cells were harvested 
by scraping in phosphate-buffered saline containing 0.4 mM Na3VO4. Cells were centrifuged and 
lysed in ice-cold lysis buffer containing 1% Triton X-100 for 20 min. Lysates were disrupted by a 
tight-fitting Dounce homogenizer. The cell lysate was centrifuged at 1300g for 5 min at 4 °C, and 
the postnuclear supernatant (PNS) was transferred to an eppendorf tube. 1 ml of PNS was mixed 
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with 1 ml of ice-cold 85% w/v sucrose and then overlaid with 5.5 ml of 30% and 4 ml 5% w/v 
sucrose. Tubes were centrifuged at 200,000g for 17 h at 4 °C in a Ultracentrifuge (Beckman 
Coulter). Different fractions (1 ml/fraction) were collected sequentially from the top of the gradient 
(fraction 1) to the bottom (fraction 11). In order to confirm the purification of lipid rafts, the content 
of CHOL, SM and flotillin-1 was determined in each fraction by HP-TLC and WB.  
 
2.3 Western blot analysis for flotillin-1 
 All fractions were separated by SDS-PAGE (10% polyacrylamide gel) and transferred onto 
a polyvinylidene difluoride (PVDF) membrane overnight then blocked in blocking buffer consisting 
of 5% (w/v) dried non-fat milk in Tris-buffered saline (T-TBS: 10 mM Tris/HCl, pH 7.5, 150 mM 
NaCl, 0.1% (v/v) Tween®20) at room temperature for 1 h. The blots were treated with anti-flotillin-
1 primary antibodies diluted 1:200 in blocking buffer at room temperature for 2 h, washed with T-
TBS and incubated with the proper secondary antibody in blocking buffer at room temperature for 1 
h. The protein bands were visualized using enhanced chemiluminescence (ECL) reagents 
(PerkinElmer, USA). 
 
2.4 Lipid composition analysis 
 Lipids were extracted from each fraction with three different chloroform/methanol mixtures 
(1/1, 1/2 and 2/1, v/v) and partitioned with the theoretical upper phase (TUP, 
chloroform/methanol/water, 47/48/1, by volume) and then with water. The organic phase was dried 
and then suspended in chloroform/methanol (2/1, v/v) for the analysis of CHOL and SM. 
Free CHOL and SM were quantified by HP-TLC with hexane/ether/glacial acetic acid (90/10/1 by 
volume) and with chloroform/methanol/glacial acetic acid/water (60/45/4/2 by volume), 
respectively. CHOL was visualized with a solution of copper sulphate in phosphoric acid at 180 °C, 
while SM with anisaldehyde in acetic acid and sulphuric acid at 120 °C. CHOL and SM standards 
were spotted on the same plate. 
 
2.5 Atomic Force Microscopy 
 A Nanoscope Multimode IIId (Bruker, Santa Barbara, CA, USA) AFM equipped with a 12 
μm piezo scanner was used for the morpho-dimensional characterization of the different fractions of 
MDA-MB-231 cell membranes purified by ultracentrifugation. 
Topography AFM images were collected in tapping mode [21] using the RMS amplitude of the 
cantilever as feedback signal operating in a saline liquid buffer. Rectangular nitrate silicon probes 
were used with nominal spring constant around 2.5 N/m (NT-MDT, Russia) and cantilever length of 
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120 μm. The cantilever resonance frequency was about 30 kHz. The RMS free amplitude of the 
cantilever was on the order of 15 nm and the relative set-point above 95% of the free amplitude. 
Images were recorded with a slow scan rate (below 1 Hz) and a resolution of 512x512 pixel per 
image was chosen. 
 
2.6 Sample preparation for AFM imaging 
 Membrane samples were diluted 1:30 in distilled water. For AFM imaging 50 μl of diluted 
fractions, purified by ultracentrifugation, were floated on a freshly cleaved mica leaf, previously 
activated with 100 μl of  adsorption buffer (150 mM KCl, 25 mM MgCl2, 10 mM Tris/HCl, pH 
7.5). After 10 min, the sample was gently rinsed three times with recording buffer (150 mM KCl, 
10 mM Hepes/Tris, pH 7.5) to remove membrane fragments that have not been adsorbed to the 
support. Samples were visualized in tapping mode in recording buffer.  
 
2.7 Antibody labelling  
  Membrane samples, adsorbed onto mica surface and prepared as above described, were 
incubated with rabbit polyclonal anti flotillin-1 antibodies raised against amino acids 324-427 of 
flotillin-1 (Santa Cruz Biotechnology, USA) diluted 1:4 in recording buffer as reported in literature 
[22] and imaged at different times (0, 30, 60 min). This protocol allowed direct comparison of the 
same membrane samples prior and after the antibody binding. For control experiments membrane 
samples, adsorbed onto mica surface and prepared as above described, were incubated with non 
specific antibodies, namely an anti-clathrin hc mouse monoclonal antibody raised against the N-
terminus of clathrin heavy chain of human origin (Santa Cruz Biotechnology, USA) diluted 1:4 in 
recording buffer and imaged at different times (0, 30, 60 min). 
 
3. RESULTS 
 In the present work, lipid rafts resistant to non-ionic detergent (Triton X-100) extraction 
were isolated from MDA-MB-231 human breast cancer cells by ultracentrifugation on 
discontinuous sucrose gradient as described in details in Materials and Methods. The presence of 
lipid rafts was verified detecting in all the 11 collected fractions the lipid raft-associated protein 
flotillin-1 [20] by SDS-PAGE assay and WB analysis. In figure 1 the distribution of flotillin-1 in 
the 11 fractions purified by ultracentrifugation is reported. In particular, the highest flotillin-1 
content was found in the low-density fractions (fractions 5 and 6) corresponding to the 5% and 30% 
sucrose interface. 
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Moreover, the analysis of the distribution of some lipids highly present in lipid rafts, namely CHOL 
and phospholipids such as SM, carried out by HP-TLC assay confirmed the presence of these 
detergent-resistant membrane micro-domains in the 5 and 6 purified fractions. Figures 2a and 2b 
show the distribution of CHOL and SM content in all the 11 fractions purified by 
ultracentrifugation. As in the case of flotillin-1, fractions 5 and 6 have the richest content both of 
CHOL and SM thus suggesting a larger presence of lipid rafts in these samples. 
In order to perform a morpho-dimensional characterization of lipid rafts, all the 11 fractions 
purified in the ultracentrifugation process were visualized by AFM.  
In Figure 3, as an example, AFM topography images of some among the 11 fractions are reported. 
In particular, membrane patches with lateral sizes of a few microns and height of about 4 nm, as 
awaited for lipid bilayers, are clearly visible in the fractions 5 and 7. Moreover, the number of 
membrane patches decreases moving from fraction 5 to 7. AFM images of fraction 6 (not shown) 
are very similar to the fraction 5. The situation dramatically changes visualizing the other fractions, 
where only small membrane fragments with lateral dimensions of a few dozen of nanometers are 
visualized on the mica support (fractions from 1 to 4, 8 and 9). Fractions 10 and 11 show a 
continuous and homogeneous distribution of membrane fragments on the whole mica surface. It is 
worth noting that these fractions are recovered at the bottom of the tube exactly where the PNS is 
placed before the ultracentrifugation process. 
Taken together, the biochemical analyses and AFM imaging indicate that lipid rafts are mainly 
present in the low-density fractions (fractions 5 and 6) corresponding to the 5% and 30% sucrose 
interface. For this reason a more detailed AFM investigation has been performed on these fractions.   
Samples prepared from fraction 5 showed membrane patches with micro-domains protruding from 
their surface as reported in Figure 4. In particular, different regions can be easily identified: the 
mica support (1), the membrane patch (2), two membrane micro-domains (3) and finally aggregates 
(white areas) which exhibit an height of a few dozen of nanometers. 
The dimensional characterization of the structures observed in Figure 4 and obtained analysing  
several AFM topography images collected in tapping mode in buffer solution gave, for membrane 
patches, lateral sizes in the range of 1-3 μm while their thickness, on average, of about 4 nm 
suggests that lipid bilayers were visualized (see Figure 5). The lateral dimensions of the micro-
domains visualized on the membrane patch surface were mainly in the range of 100-500 nm and 
always well under 1 µm. Moreover, these regions protrude by 1-2 nm from the surrounding 
membrane as shown in the height profile reported in Figure 5 (red arrows). The brighter areas 
visible on membrane patches could be identified as protein aggregates probably produced during 
the sample deposition process and induced by the interactions with the mica support. 
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Surface roughness of membrane patches (areas like the ones labelled 2 in Figure 4) as well as of the 
membrane micro-domains (areas like the ones labelled 3 in Figure 4), expressed as differences in 
the root-mean-square of the vertical Z dimension values within the examined areas, was calculated 
according to the following equation: 
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where Zaverage is the average Z value within the examined area, Zx,y is the local Z value and N 
indicates the number of points within the area.  
Rms surface roughness values were calculated as the mean of at least 15 measurements on 50x50 
nm
2
 square areas collected on the surface of membrane patches and membrane micro-domains 
observed in several AFM topography images. Errors were estimated as standard deviation. All the 
membrane micro-domains exhibited a similar surface corrugation while in comparison the 
membrane patch surface appears to be very smooth. In particular, rms surface roughness of 0.26 ± 
0.03 nm (mean ± SD; n = 18) and of 0.11 ± 0.01 nm (mean ± SD; n = 15) were calculated for 
membrane micro-domains and for membrane patches respectively.  
The micro-domains visualized on the membrane patch surface appear to be very interesting since 
their dimensions are in line with the range expected for lipid rafts as reported extensively in 
literature [23, 24]. For this reason we also performed a high resolution AFM imaging of these areas 
aiming at obtaining more detailed insights. 
In particular, the AFM image obtained scanning an area of a few hundreds square nanometers and 
reported in Figure 6, shows a micro-domain protruding by about 1 nm from the membrane surface 
(red arrows). The micro-domain has a mean rms surface roughness of 0.25 nm, easily visible in the 
AFM image, while the surrounding membrane is very smooth with a mean rms surface roughness of 
only 0.10 nm. Moreover, the height profile points out some structural features on the micro-domain 
surface with heights lower than 1 nm and lateral sizes of a few nanometers thus suggesting the 
presence of proteins embedded in the micro-domain. Unfortunately these nanometer structures 
appear to be too soft and movable, under the AFM scanning tip, to collect better detailed images 
even applying very low forces.  
In order to obtain both more information regarding the nature of the micro-domains visualized on 
the membrane patch surface and to identify the proteins observed in these areas, we carried out also 
a study using specific antibodies. In particular, membrane patches adsorbed onto the mica surface 
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were incubated with rabbit polyclonal antibodies raised against amino acids 324-427 of flotillin-1, a 
protein segment near the C-terminus and fully exposed in the cytoplasmic side of the plasma 
membrane. Anti flotillin-1 antibodies were diluted 1:4 while AFM scanning and images were 
collected at different times (0, 30, 60 min) allowing the direct comparison of the same membrane 
patches before and after antibody binding. After just 60 min incubation with the anti flotillin-1 
antibodies, the micro-domains changed their appearance showing a surface area enlargement as 
clearly visible in Figure 7 thus indicating antibody binding.  
To demonstrate specificity and get rid of possible physisorption phenomena, as control experiment 
non specific antibodies were used. In particular, membrane samples adsorbed onto the mica surface  
were incubated with antibodies raised against a non raft protein marker (clathrin hc) [25]. Mouse 
monoclonal anti clathrin hc antibodies raised against the N-terminus of clathrin heavy chain were 
diluted 1:4 in recording buffer and AFM images were collected. The shape and dimensions of the 
micro-domains visualized at different times (0, 30, 60 min) were comparable (not shown).  
A more detailed quantitative analysis allowed to calculate that the surface area of the micro-
domains protruding from the smooth lipid membrane increased by about 20% upon antibody 
binding so confirming the protein nature of the nanometer structures visualized on the micro-
domain surface. We have estimated the increase of the surface area as follows. The contour line of a 
number of membrane patches as well as of micro-domains protruding from the membrane patch 
surface were marked before and after 60 min treatment with anti flotillin-1 antibody directly from 
several AFM images using the Image J 1.45 software (NIH, USA). The increase of the surface area 
was calculated as the percentage variation compared to the untreated sample measured in pixels. In 
particular we found a surface area increase of 20.7 ± 5.6% (mean ± SD; n = 11) and 8.3 ± 2.4% 
(mean ± SD; n = 10) for micro-domains and membrane patches respectively as shown in the 
histogram reported in Figure 8. The observed difference between the surface area increase of 
membrane patches and micro-domains caused by the antibody treatment was statistically significant 
(t-Student’s test: P < 0.01). In the control experiment, the same analysis gave an increase of the 
surface area of 8.1 ± 1.6% (mean ± SD; n = 10) and 9.4 ± 2.5% (mean ± SD; n = 10) for micro-
domains and membrane patches respectively (see Figure 8). The difference between the surface area 
increase of micro-domains, caused by the anti flotillin-1 antibody treatment, and of membrane 
patches and micro-domains in the control experiment was statistically significant (t-Student’s test: P 
< 0.01) too.  
It is worth noting that the surface area increase in the anti flotillin-1 experiment showed for 
membrane patches a normal distribution centered on about 8%, while for membrane micro-domains 
the surface area increase was distributed in two different ranges, 8-10% as for membrane patches 
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and the control experiment, and higher values around 24-27%. The following consideration could 
explain this behaviour. The sample preparation protocol for AFM imaging we used in the present 
work does not allow to select the orientation of the membrane patches visualized on the mica 
support. Since anti flotillin-1 antibody binds to the cytoplasmic side of the plasma membrane, a 
surface area increase of about 10% could be awaited for membrane micro-domains exposing the 
external face of the plasma membrane due to non specific physisorption phenomena. Consequently, 
the surface area increase of about 20%, calculated for the membrane micro-domains and induced by 
the anti flotillin-1 antibody binding, could be an underestimation of the real value.  
Moreover, although the enlargement of the micro-domain surface area is the more evident effect 
visible in AFM images (see Figure 7), it is expected that antibody binding should also result in an 
increase of height and surface corrugation of the micro-domains [26].  
The analysis of the height profiles derived from cross-sections perpendicular to the micro-domain 
long axis and obtained by AFM topography images collected before and after the anti flotillin-1 
treatment made difficult to quantify a reliable difference even if the experimental data showed a 
slight increase of the micro-domain height and the height profiles exhibited a higher corrugation 
after the antibody binding. Quantitative information were obtained by the analysis of the rms 
surface roughness. In particular, the rms surface roughness of the membrane micro-domains, 
measured on 50x50 nm
2
 square areas, increased from 0.25 ± 0.03 nm (mean ± SD; n = 11) to 0.34 ± 
0.03 nm (mean ± SD; n = 11) after the antibody binding.  
The experimental data pointing out the effect induced by the antibody specific binding suggest the 
presence of flotillin-1 in the membrane micro-domains. Moreover, the flotillin-1 recognition, a lipid 
raft-associated protein [20], and its high content in these membrane micro-domains strongly support 
the hypothesis that the areas visualized in the AFM images and protruding from the membrane 
patch surface could be identified as lipid rafts.  
 
4. DISCUSSION AND CONCLUSIONS  
  Lipid rafts, small and highly dynamic micro-domains enriched in SM and CHOL located in 
the native biological membranes [1, 2], are suggested to play a significant role in many cellular 
processes such as membrane trafficking, signal transduction and regulation of membrane protein 
activity [1, 6, 7].  
Many experimental tools have been used to identify lipid rafts and to clarify their physiological 
significance even if, till now, their existence is still a contentious topic. Along with specific 
antibodies for detecting raft proteins, bacterial toxins that target lipid components are often used as 
raft markers [27-29]. AFM has been shown to be a very useful technique to visualize and 
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quantitatively characterize the topology of biological membranes also in physiological-like 
conditions [17-19]. In the present study we applied tapping mode AFM imaging to investigate lipid 
rafts of MDA-MB-231 human breast cancer cells. In tapping mode AFM the tip, mounted at the end 
of a cantilever vibrating at its resonant frequency, is placed near the sample and taps the surface 
only at the end of each oscillation cycle. The cantilever amplitude is held constant by altering the 
vertical position of the scanner. The topography image is then computed from the changes in 
scanner vertical position. Because the tip only makes intermittent contact with the sample, the 
lateral forces applied to the surface during the scanning are reduced and so tapping mode AFM is a 
very efficient imaging mode to study soft samples such as biological macromolecules and bio-
membranes. Morpho-dimensional AFM analysis was also coupled with WB and HP-TLC assays to 
obtain a biochemical characterization of the structures visualized in AFM images. Membrane 
patches of MDA-MB-231 cell resistant to Triton X-100 extraction were purified by 
ultracentrifugation on a discontinuous sucrose gradient. All the 11 isolated fractions were analysed 
with respect to their flotillin-1 content by SDS-PAGE and WB assays. Fractions 5 and 6 showed the 
highest levels of flotillin-1, a lipid raft associated protein [20], as reported in Figure 1. Moreover, 
HP-TLC analysis detected in the same purified fractions the highest content of CHOL and SM, 
lipids highly present in lipid rafts (see Figure 2). The biochemical data therefore confirm a larger 
presence of lipid rafts in the low-density fractions 5 and 6 corresponding to the 5% and 30% 
sucrose interface. In agreement with biochemical analyses, AFM imaging visualized large and 
planar membrane patches with lateral sizes of a few microns and an height of about 4-5 nm, as 
awaited for single lipid bilayers, only in the fractions with the richest content of flotillin-1, CHOL 
and SM (see Figure 3). Moreover, the number of the membrane patches decreases from fraction 5 to 
7 as well as the flotillin-1, CHOL and SM content.  
Classical preparation of  lipid rafts uses 1% Triton X-100 to extract detergent resistant membranes 
which are then separated by ultracentrifugation on 5%-30% sucrose density gradient. Recently, 
different methods have been developed using a variety of other detergents or with detergent free 
techniques [30]. Some observations raised the hypothesis that treatment of cells with detergents 
may generate clusters of raft lipids and proteins that did not exist in the intact cells. Our data 
showed in fractions 5 and 6 the presence of membrane patches of 1-3 µm that may be formed 
through a mechanism of coalescence as a result of detergent treatment. Nevertheless recent data 
demonstrated that Triton X-100 does not induce domain formation or increase the fraction of the 
bilayer in the ordered state, although it does increase domain size by coalescing pre-existing 
domains [30]. Thus our observations are in agreement with this theory.  
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Interestingly high resolution AFM imaging of samples prepared from fraction 5 showed micro-
domains protruding from the membrane patches by 1-2 nm and with lateral dimensions in the range 
of 100-500 nm in line with the range expected for lipid rafts [23, 24] as shown in Figures 4 and 5. 
In addition, while the surrounding membrane appears to be very smooth (rms surface roughness =  
0.11 ± 0.01 nm; mean ± SD, n = 15), the micro-domain exhibits a surface corrugation (rms surface 
roughness = 0.26 ± 0.03 nm; mean ± SD, n = 18) with nanometer features on its surface which 
resemble proteins in both size and shape (see Figure 6).  
The incubation of membrane patches with anti flotillin-1 antibody proved the protein nature of the 
structures visualized on the micro-domain surface as well as the presence of flotillin-1 among these 
proteins. In fact, as reported in Figure 7, just after 60 min of anti flotillin-1 antibody treatment the 
micro-domains changed their size and appearance showing an evident enlargement of the surface 
area. In particular the micro-domain surface area increased by about 20% while membrane patches 
showed an average increase of only about 8% (see Figure 8). The observed difference was 
statistically significant (t-Student’s test: P < 0.01). Besides, membrane micro-domains exhibited a 
higher surface corrugation after the antibody binding and their rms surface roughness increased 
from 0.25 ± 0.03 nm (mean ± SD; n = 11) to 0.34 ± 0.03 nm (mean ± SD; n = 11).  
On the contrary, control experiments carried out using anti clathrin hc, a non specific antibody 
raised against a non raft protein marker [25], showed an average increase of the surface area of 
about 8% for micro-domains as well as for membrane patches (see Figure 8). The increase of the 
membrane patch surface area, of the same order both in the anti flotillin-1 treated and control 
experiments, could be caused by re-aggregation processes of lipid aggregates not well adhered to 
the mica support. 
Interestingly, the increase of the surface area of the membrane micro-domains induced by the anti 
flotillin-1 treatment showed values distributed in two different ranges, 8-10% and 24-27%. These 
differences can be justified taken in account that the sample preparation protocol for AFM imaging 
does not allow to select the orientation of the membrane patches on the mica support. Since anti 
flotillin-1 binds to the cytoplasmic side of the plasma membrane, the 8-10% surface area increase 
could be induced by non specific physisorption phenomena on micro-domains exposing the external 
face of the membrane. As a result the increase of the micro-domain surface area of about 20% 
induced by the anti flotillin-1 antibody binding could be an underestimation of the real value.  
 
4.1 Concluding remarks 
 Taken together the biochemical data as well as the flotillin-1 recognition and its high content 
in the membrane micro-domains, strongly indicate that the nanometer areas protruding from the 
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membrane patch surface and visualized in AFM images are lipid rafts. Moreover, our results are in 
favourable agreement with data reported in literature and obtained using different experimental 
approaches [2]. We believe that further applications of AFM imaging to lipid raft topic in both 
healthy and pathological native biological membranes coupled with a detailed biochemical 
investigation could contribute to better understanding some basic properties and molecular 
mechanisms of this important biological phenomenon. 
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FIGURE CAPTIONS 
 
Figure 1. 
Distribution of flotillin-1 in Triton X-100 isolated MDA-MB-231 human breast cancer cell membranes. 
Triton X-100 lysates of cell cultures were purified and fractionated by sucrose gradient ultracentrifugation. 
Equal volumes of each fraction were analysed by Western Blotting with antibodies to flotillin-1 protein. 
Fractions 5 and 6 have the highest flotillin-1 content. 
 
Figure 2. 
Distribution of CHOL (a) and SM (b) content in Triton X-100 isolated MDA-MB-231 human breast cancer 
cell membranes. Triton X-100 lysates of cell cultures were purified and fractionated by sucrose gradient 
ultracentrifugation. Equal volumes of each fraction were analysed by HP-TLC. Fractions 5 and 6 have the 
highest content of CHOL and SM. 
 
Figure 3. 
 AFM topography images of some isolated fractions. Purified membranes were diluted 1:30 in distilled water 
and 50 μl of the suspension placed on a mica support. AFM images were collected in liquid buffer in tapping 
mode. Different situations were visualized: membrane patches with lateral sizes of a few microns and height 
of 4 nm (fractions from 5 to 7), small membrane fragments (fractions from 1 to 4, 8 and 9) and an 
homogeneous distribution of membrane fragments on the whole support (fractions 10 and 11). For all the 
images: scan area = 10x10 μm2; z range (from darkest to lightest) = 20 nm; scale bar = 1 μm. 
 
Figure 4.  
AFM topography image of a membrane sample prepared from fraction 5 collected in liquid buffer in tapping 
mode. Different regions are visualized: the mica support (1), a membrane patch (2), two micro-domains 
protruding from the membrane surface (3) and higher aggregates (white areas).  
Scan area = 1.5x1.5 μm2; z range (from darkest to lightest) = 15 nm. 
 
Figure 5. 
(left) AFM topography image of a membrane sample prepared from fraction 5 and collected in liquid buffer 
in tapping mode. The image shows a membrane patch 4 nm thick (green arrows) with two micro-domains 
and some protein aggregates (brighter areas). (right) Height profile corresponding to the black line drawn 
in AFM image. The micro-domain protrudes by 2 nm from the membrane surface (red arrows). Scan area = 
1.6x1.6 μm2; z range (from darkest to lightest) = 20 nm.      
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Figure 6.  
(left) High resolution AFM topography image of a membrane sample prepared from fraction 5 and collected 
in liquid buffer in tapping mode. The image shows a micro-domain (1) which protrudes by about 1 nm from 
the surface (2) of the membrane patch (red arrows). The micro-domain has a surface roughness while the 
surrounding membrane is very smooth. (right) Height profile corresponding to the black line drawn in AFM 
image. Nanometer features are visible on the micro-domain surface comparable for dimensions with 
proteins. Scan area =  200x200 nm
2
; z range (from darkest to lightest) = 2 nm.     
 
Figure 7.  
AFM topography images of membrane samples prepared from fraction 5 and collected in liquid buffer in 
tapping mode. Untreated membrane patches (a) were incubated with anti flotillin-1 antibody (1:4 in 
adsorption buffer) for different times (0, 30, 60 min). Just after 60 min of treatment (b) the surface area of 
micro-domains protruding from the membrane patches clearly increases (see circled areas) thus suggesting 
the presence of flotillin-1 proteins. Scan area = 5x5 μm2;  z range (from darkest to lightest) = 25 nm.     
 
Figure 8. 
Histogram of the surface area increase for membrane patches, 8.3 ± 2.4% (mean ± SD; n = 10),  and micro-
domains,  20.7 ± 5.6% (mean ± SD; n = 11), after 60 min anti flotillin-1 antibody incubation (gray bars) and 
of the surface area increase for membrane patches, 9.4 ± 2.5% (mean ± SD; n = 10),  and micro-domains, 
8.1 ± 1.6% (mean ± SD; n = 10), in the control experiment after 60 min anti clathrin hc antibody incubation 
(white bars). The observed difference among the surface area increase of the micro-domains, induced by the 
anti flotillin-1 treatment, and of membrane patches both in the anti flotillin-1 treated and control experiment 
as well as of the micro-domains in the control experiment is statistically significant (t-Student’s test: P < 
0.01). 
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ABSTRACT 
 Several Recent studies suggest that the plasma membrane is composed of micro-domains of 
saturated lipids that segregate together to form lipid rafts. Lipid rafts have been operationally 
defined as cholesterol- and sphingolipid-enriched membrane micro-domains resistant to 
solubilisation by non-ionic detergents at low temperatures. Here we report a biophysical approach 
aimed at investigating lipid rafts of MDA-MB-231 human breast cancer cells by coupling an 
Atomic Force Microscopy (AFM) study to biochemical assays namely Western Blotting and High 
Performance Thin Layer Chromatography. Lipid rafts were purified by ultracentrifugation on 
discontinuous sucrose gradient using extraction with Triton X-100. Biochemical analyses proved 
that the fractions isolated at the 5% and 30% sucrose interface (fractions 5 and 6) have an higher 
content of cholesterol, sphingomyelin and flotillin-1 with respect to the other purified fractions. 
Tapping mode AFM imaging of fraction 5 showed membrane patches whose height corresponds to 
the one awaited for a single lipid bilayer as well as the presence of micro-domains with lateral 
dimensions in the order of a few hundreds of nanometers. In addition, an AFM study using specific 
antibodies suggests the presence, in these micro-domains, of a characteristic marker of lipid rafts, 
the protein flotillin-1. 
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1. INTRODUTION  
 Accumulating evidence indicates that cell membrane constituents might be not randomly 
distributed but rather organized Recent findings in membrane biology suggest that cell membrane 
constituents might be organized in small lipid/protein domains enriched in sphingomyelin (SM) and 
cholesterol (CHOL), known as lipid rafts [1, 2]. Lipid rafts are small, heterogeneous, highly 
dynamic, sterol- and sphingolipid-enriched domains resistant to solubilisation by non-ionic 
detergents (traditionally Triton X-100) at low temperatures [3]. Moreover, lipid rafts are enriched in 
GPI-anchored proteins [4] and also contain several signaling proteins, including for instance the 
epidermal growth factor receptor (EGFR) [5]. Proof of the existence of lipid rafts is based largely 
on biochemical evidence even if the lipid raft hypothesis is still a contentious topic, with much of 
the scientific community divided. In particular, the inability to visualize lipid rafts directly in cell 
membranes, as well as a lack of understanding of some basic properties (e.g. size and lifetime), has 
led to controversy over their definition and existence. 
To date, a large number of experimental results converge toward the idea that lateral domains 
enriched in SM and CHOL exist in native biological membranes. These micro-domains have been 
suggested to take part in various dynamic cellular processes such as membrane trafficking, signal 
transduction, and regulation of the activity of membrane proteins [1, 6, 7].  
In model membranes, the coexistence of domains in liquid ordered and liquid disordered phases is 
widely accepted [8, 9]. Self-associative properties unique to sphingolipids and CHOL in vitro could 
facilitate selective lateral segregation in the membrane plane and serve as a basis for lipid sorting in 
vivo [1]. Direct evidence of lipid rafts in vivo is mainly based on monitoring the motions of 
membrane proteins [2] or on differential partitioning of fluorescent probes in membrane 
environments [10].  
Studying lipid rafts is challenging since they with dimensions of a few hundreds nanometers, are 
probably too small to be resolved by techniques such as optical and fluorescence microscopy. High   
However, super resolution microscopy offers, in principle, the possibility to investigate samples 
with these size ranges. For example, Transmission Electron Microscope can visualize a 5-
nanometer-thick cell membrane but it requires an invasive sample preparation (drying, staining and 
ultra high vacuum). For example, stimulated-emission-depletion (STED) nanoscopy (10) provided 
direct evidence in live cells that certain lipids are transiently trapped in CHOL-assisted molecular 
complexes (11, 12, 13). These studies revealed that the extent of the areas in which the lipids dwell 
during trapping is about  20 nm in diameter (11). Photoactivated localization microscopy (PALM) 
is another powerful approach for investigating protein/lipid organization. Combining pair-
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correlation analysis with PALM provided a method to analyze complex patterns of protein 
organization across the plasma membrane demonstrating a distinct nanoscale organization of 
plasma membrane proteins with different membrane anchoring and lipid partitioning characteristics 
in COS-7 cells as well as dramatic changes in GPI-anchored protein arrangement under varying 
perturbations (14). Moreover, PALM imaging proved that CHOL- and sphingolipid-enriched micro-
domains occupy different regions on the plasma membrane with lateral dimensions in the order of 
an hundred of nanometers (15). On the contrary, Atomic Force Microscopy (AFM), providing 
nanometer spatial resolution and operating in physiological-like conditions without fixation, 
staining, or labelling, appears to be an useful tool to quantitatively perform a morpho-dimensional 
characterization of lipid rafts as well as of their protein content [16]. Moreover, thanks to its high 
signal-to-noise ratio, AFM allows to monitor function related structural conformational changes and 
to observe structural details of membrane proteins under physiological conditions, revealing 
information on the protein oligomeric state and on the supramolecular architecture of membrane 
protein complexes [17-19]. 
 In this work we applied AFM, together with biochemical assays, namely Western Blotting 
(WB) and High Performance Thin Layer Chromatography (HP-TLC), to the study of lipid rafts of 
MDA-MB-231 human breast cancer cells. In particular, the different fractions, isolated in the 
purification process by ultracentrifugation on sucrose gradient, have been analysed with respect to 
their lipid content and morpho-dimensionally characterized. Interestingly, AFM imaging of the 
purified fractions with the richest CHOL and SM content, showed membrane micro-domains with 
lateral dimensions of a few hundreds of nanometers. Moreover, treating the samples with a specific 
antibody against the protein flotillin-1, an increase of the micro-domain surface area occurs thus 
suggesting the presence of flotillin-1, a lipid raft-associated protein [20], in the visualized 
membrane micro-domains.  
 
2. MATERIALS AND METHODS 
2.1 Cell line and culture conditions 
 Human breast cancer cell line MDA-MB-231 (ER-negative and over-expressing EGFR), 
derived from human mammary adenocarcinoma, were obtained from Italian National Cancer 
Research Institute cell bank. The MDA-MB-231 cell line was maintained in DMEM medium 
(Gibco-BRL, Life Technologies Italia srl, Italy) supplemented with 10% fetal bovine serum (FBS), 
100 U/ml penicillin, 100 mg/ml streptomycin and 2 mM glutamine. Cells were grown at 37 °C in a 
5% CO2 atmosphere with 98% relative humidity. 
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2.2 Lipid raft isolation 
 Cells were seeded at 1.5 x 10
4
 cells/cm
2
 in DMEM medium. After 48 h, cells were harvested 
by scraping in phosphate-buffered saline containing 0.4 mM Na3VO4. Cells were centrifuged and 
lysed in ice-cold lysis buffer containing 1% Triton X-100 for 20 min. Lysates were disrupted by a 
tight-fitting Dounce homogenizer. The cell lysate was centrifuged at 1300g for 5 min at 4 °C, and 
the postnuclear supernatant (PNS) was transferred to an eppendorf tube. 1 ml of PNS was mixed 
with 1 ml of ice-cold 85% w/v sucrose and then overlaid with 5.5 ml of 30% and 4 ml 5% w/v 
sucrose. Tubes were centrifuged at 200,000g for 17 h at 4 °C in a Ultracentrifuge (Beckman 
Coulter). Different fractions (1 ml/fraction) were collected sequentially from the top of the gradient 
(fraction 1) to the bottom (fraction 11). In order to confirm the purification of lipid rafts, the content 
of CHOL, SM and flotillin-1 was determined in each fraction by HP-TLC and WB.  
 
2.3 Western blot analysis for flotillin-1 
 All fractions were separated by SDS-PAGE (10% polyacrylamide gel) and transferred onto 
a polyvinylidene difluoride (PVDF) membrane overnight then blocked in blocking buffer consisting 
of 5% (w/v) dried non-fat milk in Tris-buffered saline (T-TBS: 10 mM Tris/HCl, pH 7.5, 150 mM 
NaCl, 0.1% (v/v) Tween®20) at room temperature for 1 h. The blots were treated with anti-flotillin-
1 primary antibodies diluted 1:200 in blocking buffer at room temperature for 2 h, washed with T-
TBS and incubated with the proper secondary antibody in blocking buffer at room temperature for 1 
h. The protein bands were visualized using enhanced chemiluminescence (ECL) reagents 
(PerkinElmer, USA). 
 
2.4 Lipid composition analysis 
 Lipids were extracted from each fraction with three different chloroform/methanol mixtures 
(1/1, 1/2 and 2/1, v/v) and partitioned with the theoretical upper phase (TUP, 
chloroform/methanol/water, 47/48/1, by volume) and then with water. The organic phase was dried 
and then suspended in chloroform/methanol (2/1, v/v) for the analysis of CHOL and SM. 
Free CHOL and SM were quantified by HP-TLC with hexane/ether/glacial acetic acid (90/10/1 by 
volume) and with chloroform/methanol/glacial acetic acid/water (60/45/4/2 by volume), 
respectively. CHOL was visualized with a solution of copper sulphate in phosphoric acid at 180 °C, 
while SM with anisaldehyde in acetic acid and sulphuric acid at 120 °C. CHOL and SM standards 
were spotted on the same plate. 
 
 5 
 
2.5 Atomic Force Microscopy 
 A Nanoscope Multimode IIId (Bruker, Santa Barbara, CA, USA) AFM equipped with a 12 
μm piezo scanner was used for the morpho-dimensional characterization of the different fractions of 
MDA-MB-231 cell membranes purified by ultracentrifugation. 
Topography AFM images were collected in tapping mode [21] using the RMS amplitude of the 
cantilever as feedback signal operating in a saline liquid buffer. Rectangular nitrate silicon probes 
were used with nominal spring constant around 2.5 N/m (NT-MDT, Russia) and cantilever length of 
120 μm. The cantilever resonance frequency was about 30 kHz. The RMS free amplitude of the 
cantilever was on the order of 15 nm and the relative set-point above 95% of the free amplitude. 
Images were recorded with a slow scan rate (below 1 Hz) and a resolution of 512x512 pixel per 
image was chosen. 
 
2.6 Sample preparation for AFM imaging 
 Membrane samples were diluted 1:30 in distilled water. For AFM imaging 50 μl of diluted 
fractions, purified by ultracentrifugation, were floated on a freshly cleaved mica leaf, previously 
activated with 100 μl of adsorption buffer (150 mM KCl, 25 mM MgCl2, 10 mM Tris/HCl, pH 7.5). 
After 10 min, the sample was gently rinsed three times with recording buffer (150 mM KCl, 10 mM 
Hepes/Tris, pH 7.5) to remove membrane fragments that have not been adsorbed to the support. 
Samples were visualized in tapping mode in recording buffer.  
 
2.7 Antibody labelling of flotillin-1 
  Membrane samples, adsorbed onto mica surface and prepared as above described, were 
incubated with rabbit polyclonal anti flotillin-1 antibodies raised against amino acids 324-427 of 
flotillin-1 (Santa Cruz Biotechnology, USA) diluted 1:4 in recording buffer as reported in literature 
[22] and imaged at different times (0, 30, 60 min). This protocol allowed direct comparison of the 
same membrane samples prior and after the antibody binding. For control experiments 70 µL of 
recording buffer were poured on the membrane samples and AFM images were collected at 
different times (0, 30, 60 min). For control experiments membrane samples, adsorbed onto mica 
surface and prepared as above described, were incubated with non specific antibodies, namely an 
anti-clathrin hc mouse monoclonal antibody raised against the N-terminus of clathrin heavy chain 
of human origin (Santa Cruz Biotechnology, USA) diluted 1:4 in recording buffer and imaged at 
different times (0, 30, 60 min). 
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3. RESULTS 
 In the present work, lipid rafts resistant to non-ionic detergent (Triton X-100) extraction 
were isolated from MDA-MB-231 human breast cancer cells by ultracentrifugation on 
discontinuous sucrose gradient as described in details in Materials and Methods. The presence of 
lipid rafts was verified detecting in all the 11 collected fractions the lipid raft-associated protein 
flotillin-1 [20] by SDS-PAGE assay and WB analysis. In figure 1 the distribution of flotillin-1 in 
the 11 fractions purified by ultracentrifugation is reported. In particular, the highest flotillin-1 
content was found in the low-density fractions (fractions 5 and 6) corresponding to the 5% and 30% 
sucrose interface. 
Moreover, the analysis of the distribution of some lipids highly present in lipid rafts, namely CHOL 
and phospholipids such as SM, carried out by HP-TLC assay confirmed the presence of these 
detergent-resistant membrane micro-domains in the 5 and 6 purified fractions. Figures 2a and 2b 
show the distribution of CHOL and SM content in all the 11 fractions purified by 
ultracentrifugation. As in the case of flotillin-1, fractions 5 and 6 have the richest content both of 
CHOL and SM thus suggesting a larger presence of lipid rafts in these samples. 
In order to perform a morpho-dimensional characterization of lipid rafts, all the 11 fractions 
purified in the ultracentrifugation process were visualized by AFM. This microscopy technique 
offers the possibility to observe biological specimens, such as cell membranes, with nanometer 
resolution in buffer solution without the need to preliminary treatments as sample fixation, staining 
or labelling. Thus, measurements can be made under near-native conditions in an aqueous 
environment.  
In Figure 3, as an example, AFM topography images of some among the 11 fractions are reported. 
In particular, membrane patches with lateral sizes of a few microns and height of about 4 nm, as 
awaited for lipid bilayers, are clearly visible in the fractions 5 and 7. Moreover, the number of 
membrane patches decreases moving from fraction 5 to 7. AFM images of fraction 6 (not shown) 
are very similar to the fraction 5. The situation dramatically changes visualizing the other fractions, 
where only small membrane fragments with lateral dimensions of a few dozen of nanometers are 
visualized on the mica support (fractions from 1 to 4, 8 and 9). Fractions 10 and 11 show a 
continuous and homogeneous distribution of membrane fragments on the whole mica surface. It is 
worth noting that these fractions are recovered at the bottom of the tube exactly where the PNS is 
placed before the ultracentrifugation process. 
Taken together, the biochemical analyses and AFM imaging indicate that lipid rafts are mainly 
present in the low-density fractions (fractions 5 and 6) corresponding to the 5% and 30% sucrose 
interface. For this reason a more detailed AFM investigation has been performed on these fractions.   
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Samples prepared from fraction 5 showed membrane patches with micro-domains protruding from 
their surface as reported in Figure 4. In particular, different regions can be easily identified: the 
mica support (1), the membrane patch (2), two membrane micro-domains (3) and finally aggregates 
(white areas) which exhibit an height of a few dozen of nanometers. 
The dimensional characterization of the structures observed in Figure 4 and obtained analysing  
several AFM topography images collected in tapping mode in buffer solution gave, for membrane 
patches, lateral sizes in the range of 1-3 μm while their thickness, on average, of about 4 nm 
suggests that lipid bilayers were visualized (see Figure 5). The lateral dimensions of the micro-
domains visualized on the membrane patch surface were mainly in the range of 100-500 nm and 
always well under 1 µm. Moreover, these regions protrude by 1-2 nm from the surrounding 
membrane as shown in the height profile reported in Figure 5 (red arrows). The brighter areas 
visible on membrane patches could be identified as protein aggregates probably produced during 
the sample deposition process and induced by the interactions with the mica support. 
Surface roughness of membrane patches (areas like the ones labelled 2 in Figure 4) as well as of the 
membrane micro-domains (areas like the ones labelled 3 in Figure 4), expressed as differences in 
the root-mean-square of the vertical Z dimension values within the examined areas, was calculated 
according to the following equation: 
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where Zaverage is the average Z value within the examined area, Zx,y is the local Z value and N 
indicates the number of points within the area.  
Rms surface roughness values were calculated as the mean of at least 15 measurements on 50x50 
nm
2
 square areas collected on the surface of membrane patches and membrane micro-domains 
observed in several AFM topography images. Errors were estimated as standard deviation. All the 
membrane micro-domains exhibited a similar surface corrugation while in comparison the 
membrane patch surface appears to be very smooth. In particular, rms surface roughness of 0.26 ± 
0.03 nm (mean ± SD; n = 18) and of 0.11 ± 0.01 nm (mean ± SD; n = 15) were calculated for 
membrane micro-domains and for membrane patches respectively.  
The micro-domains visualized on the membrane patch surface appear to be very interesting since 
their dimensions are in line with the range expected for lipid rafts as reported extensively in 
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literature [23, 24]. For this reason we also performed a high resolution AFM imaging of these areas 
aiming at obtaining more detailed insights. 
In particular, the AFM image obtained scanning an area of a few hundreds square nanometers and 
reported in Figure 6, shows a micro-domain protruding by about 1 nm from the membrane surface 
(red arrows). The micro-domain has a mean rms surface roughness (white spots) of 0.25 nm, easily 
visible in the AFM image, while the surrounding membrane is appears to be very smooth with a 
mean rms surface roughness of only 0.10 nm. Moreover, the height profile points out some 
structural features on the micro-domain surface with heights lower than 1 nm and lateral sizes of a 
few nanometers thus suggesting the presence of proteins embedded in the micro-domain. 
Unfortunately these nanometer structures appear to be too soft and movable, under the AFM 
scanning tip, to collect better detailed images even applying very low forces.  
In order to obtain both more information regarding the nature of the micro-domains visualized on 
the membrane patch surface and to identify the proteins observed in these areas, we carried out also 
a study using specific antibodies. In particular, membrane patches adsorbed onto the mica surface 
were incubated with anti flotillin-1 antibody,  rabbit polyclonal antibodies raised against amino 
acids 324-427 of flotillin-1, a protein segment near the C-terminus and fully exposed in the 
cytoplasmic side of the plasma membrane. a polyclonal antibody against the N-terminus of flotillin-
1, Anti flotillin-1 antibodies were diluted 1:4 while AFM scanning and images were collected at 
different times (0, 30, 60 min) allowing the direct comparison of the same membrane patches before 
and after antibody binding. After just 60 min incubation with the anti flotillin-1 antibodies, the 
micro-domains changed their appearance showing a surface area enlargement as clearly visible in 
Figure 7 thus indicating antibody binding. As a control, 70 µL of recording buffer were poured on 
membrane patches and AFM images were collected. The shape and dimensions of the micro-
domains visualized at different times (0, 30, 60 min) were comparable (not shown). 
To demonstrate specificity and get rid of possible physisorption phenomena, as control experiment 
non specific antibodies were used. In particular, membrane samples adsorbed onto the mica surface  
were incubated with antibodies raised against a non raft protein marker (clathrin hc) [25]. Mouse 
monoclonal anti clathrin hc antibodies raised against the N-terminus of clathrin heavy chain were 
diluted 1:4 in recording buffer and AFM images were collected. The shape and dimensions of the 
micro-domains visualized at different times (0, 30, 60 min) were comparable (not shown).  
A more detailed quantitative analysis allowed to calculate that the surface area of the micro-
domains protruding from the smooth lipid membrane increased by about 20% upon antibody 
binding so confirming the protein nature of the nanometer structures visualized on the micro-
domain surface. We have estimated the increase of the surface area as follows. The contour line of a 
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number of membrane patches as well as of micro-domains protruding from the membrane patch 
surface were marked before and after 60 min treatment with anti flotillin-1 antibody directly from 
several AFM images using the Image J 1.45 software (NIH, USA). The increase of the surface area 
was calculated as the percentage variation compared to the untreated sample measured in pixels. In 
particular we found a surface area increase of 17.8 ± 6.1% (mean ± SD; n = 12) 20.7 ± 5.6% (mean 
± SD; n = 11) and 7.9 ± 1.5% (mean ± SD; n = 10) 8.3 ± 2.4% (mean ± SD; n = 10) for micro-
domains and membrane patches respectively as shown in the histogram reported in Figure 8. The 
observed difference between the surface area increase of membrane patches and micro-domains 
caused by the antibody treatment was statistically significant (t-Student’s test: P < 0.01). In the 
control experiment, the same analysis gave an increase of the surface area of 6.7 ± 1.7% (mean ± 
SD; n = 10) 8.1 ± 1.6% (mean ± SD; n = 10) and 8.8 ± 1.9% (mean ± SD; n = 10) 9.4 ± 2.5% (mean 
± SD; n = 10) for micro-domains and membrane patches respectively (see Figure 8). The difference 
between the surface area increase of micro-domains, caused by the anti flotillin-1 antibody 
treatment, and of membrane patches and micro-domains in the control experiment was statistically 
significant (t-Student’s test: P < 0.01) too.  
It is worth noting that the surface area increase in the anti flotillin-1 experiment showed for 
membrane patches a normal distribution centered on about 8%, while for membrane micro-domains 
the surface area increase was distributed in two different ranges, 8-10% as for membrane patches 
and the control experiment, and higher values around 24-27%. The following consideration could 
explain this behaviour. The sample preparation protocol for AFM imaging we used in the present 
work does not allow to select the orientation of the membrane patches visualized on the mica 
support. Since anti flotillin-1 antibody binds to the cytoplasmic side of the plasma membrane, a 
surface area increase of about 10% could be awaited for membrane micro-domains exposing the 
external face of the plasma membrane due to non specific physisorption phenomena. Consequently, 
the surface area increase of about 20%, calculated for the membrane micro-domains and induced by 
the anti flotillin-1 antibody binding, could be an underestimation of the real value.  
Moreover, although the enlargement of the micro-domain surface area is the more evident effect 
visible in AFM images (see Figure 7), it is expected that antibody binding should also result in an 
increase of height and surface corrugation of the micro-domains [26].  
The analysis of the height profiles derived from cross-sections perpendicular to the micro-domain 
long axis and obtained by AFM topography images collected before and after the anti flotillin-1 
treatment made difficult to quantify a reliable difference even if the experimental data showed a 
slight increase of the micro-domain height and the height profiles exhibited a higher corrugation 
after the antibody binding. Quantitative information were obtained by the analysis of the rms 
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surface roughness. In particular, the rms surface roughness of the membrane micro-domains, 
measured on 50x50 nm
2
 square areas, increased from 0.25 ± 0.03 nm (mean ± SD; n = 11) to 0.34 ± 
0.03 nm (mean ± SD; n = 11) after the antibody binding.  
The experimental data pointing out the effect induced by the antibody specific binding suggest the 
presence of flotillin-1 in the membrane micro-domains. Moreover, the flotillin-1 recognition, a lipid 
raft-associated protein [20], and its high content in these membrane micro-domains strongly support 
the hypothesis that the areas visualized in the AFM images and protruding from the membrane 
patch surface could be identified as lipid rafts.  
 
4. DISCUSSION AND CONCLUSIONS  
  Lipid rafts, small and highly dynamic micro-domains enriched in SM and CHOL located in 
the native biological membranes [1, 2], are suggested to play a significant role in many cellular 
processes such as membrane trafficking, signal transduction and regulation of membrane protein 
activity [1, 6, 7].  
Many experimental tools have been used to identify lipid rafts and to clarify their physiological 
significance even if, till now, their existence is still a contentious topic. Along with specific 
antibodies for detecting raft proteins, bacterial toxins that target lipid components are often used as 
raft markers [27-29]. AFM has been shown to be a very useful technique to visualize and 
quantitatively characterize the topology of biological membranes also in physiological-like 
conditions [17-19]. In the present study we applied tapping mode AFM imaging to investigate lipid 
rafts of MDA-MB-231 human breast cancer cells. using extraction with Triton X-100 followed by 
ultracentrifugation on sucrose gradient. In tapping mode AFM the tip, mounted at the end of a 
cantilever vibrating at its resonant frequency, is placed near the sample and taps the surface only at 
the end of each oscillation cycle. The cantilever amplitude is held constant by altering the vertical 
position of the scanner. The topography image is then computed from the changes in scanner 
vertical position. Because the tip only makes intermittent contact with the sample, the lateral forces 
applied to the surface during the scanning are reduced and so tapping mode AFM is a very efficient 
imaging mode to study soft samples such as biological macromolecules and bio-membranes. 
Morpho-dimensional AFM analysis was also coupled with WB and HP-TLC assays to obtain a 
biochemical characterization of the structures visualized in AFM images. Membrane patches of 
MDA-MB-231 cell resistant to Triton X-100 extraction were purified by ultracentrifugation on a 
discontinuous sucrose gradient. All the 11 isolated fractions were analysed with respect to their 
flotillin-1 content by SDS-PAGE and WB assays. Fractions 5 and 6 showed the highest levels of 
flotillin-1, a lipid raft associated protein [20], as reported in Figure 1. Moreover, HP-TLC analysis 
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detected in the same purified fractions the highest content of CHOL and SM, lipids highly present 
in lipid rafts (see Figure 2). The biochemical data therefore confirm a larger presence of lipid rafts 
in the low-density fractions 5 and 6 corresponding to the 5% and 30% sucrose interface. In 
agreement with biochemical analyses, AFM imaging visualized large and planar membrane patches 
with lateral sizes of a few microns and an height of about 4-5 nm, as awaited for single lipid 
bilayers, only in the fractions with the richest content of flotillin-1, CHOL and SM (see Figure 3). 
Moreover, the number of the membrane patches decreases from fraction 5 to 7 as well as the 
flotillin-1, CHOL and SM content.  
Classical preparation of  lipid rafts uses 1% Triton X-100 to extract detergent resistant membranes 
which are then separated by ultracentrifugation on 5%-30% sucrose density gradient. Recently, 
different methods have been developed using a variety of other detergents or with detergent free 
techniques [30]. Some observations raised the hypothesis that treatment of cells with detergents 
may generate clusters of raft lipids and proteins that did not exist in the intact cells. Our data 
showed in fractions 5 and 6 the presence of membrane patches of 1-3 µm that may be formed 
through a mechanism of coalescence as a result of detergent treatment. Nevertheless recent data 
demonstrated that Triton X-100 does not induce domain formation or increase the fraction of the 
bilayer in the ordered state, although it does increase domain size by coalescing pre-existing 
domains [30]. Thus our observations are in agreement with this theory.  
Interestingly high resolution AFM imaging of samples prepared from fraction 5 showed micro-
domains protruding from the membrane patches by 1-2 nm and with lateral dimensions in the range 
of 100-500 nm in line with the range expected for lipid rafts [23, 24] as shown in Figures 4 and 5. 
In addition, while the surrounding membrane appears to be very smooth (rms surface roughness =  
0.11 ± 0.01 nm; mean ± SD, n = 15), the micro-domain exhibits a surface corrugation (rms surface 
roughness = 0.26 ± 0.03 nm; mean ± SD, n = 18) with nanometer features on its surface which 
resemble proteins in both size and shape (see Figure 6).  
The incubation of membrane patches with anti flotillin-1 antibody proved the protein nature of the 
structures visualized on the micro-domain surface as well as the presence of flotillin-1 among these 
proteins. In fact, as reported in Figure 7, just after 60 min of anti flotillin-1 antibody treatment the 
micro-domains changed their size and appearance showing an evident enlargement of the surface 
area. In particular the micro-domain surface area increased by about 20% while membrane patches 
showed an average increase of only about 8% (see Figure 8). Besides, The observed difference was 
statistically significant (t-Student’s test: P < 0.01). Besides, membrane micro-domains exhibited a 
higher surface corrugation after the antibody binding and their rms surface roughness increased 
from 0.25 ± 0.03 nm (mean ± SD; n = 11) to 0.34 ± 0.03 nm (mean ± SD; n = 11).  
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On the contrary, control experiments carried out using anti clathrin hc, a non specific antibody 
raised against a non raft protein marker [25], showed an average increase of the surface area of 
about 8% for micro-domains as well as for membrane patches (see Figure 8). The increase of the 
membrane patch surface area, of the same order both in the anti flotillin-1 treated and control 
experiments, could be caused by re-aggregation processes of lipid aggregates not well adhered to 
the mica support. 
Interestingly, the increase of the surface area of the membrane micro-domains induced by the anti 
flotillin-1 treatment showed values distributed in two different ranges, 8-10% and 24-27%. These 
differences can be justified taken in account that the sample preparation protocol for AFM imaging 
does not allow to select the orientation of the membrane patches on the mica support. Since anti 
flotillin-1 binds to the cytoplasmic side of the plasma membrane, the 8-10% surface area increase 
could be induced by non specific physisorption phenomena on micro-domains exposing the external 
face of the membrane. As a result the increase of the micro-domain surface area of about 20% 
induced by the anti flotillin-1 antibody binding could be an underestimation of the real value.  
On the contrary, control experiments carried out imaging membrane patches in recording buffer, 
after 60 min showed an average increase of the surface area of about 8% for micro-domains as well 
as for membrane patches (see Figure 8). The increase of the membrane patch surface area, of the 
same order both in the antibody treated and control experiments, could be caused by re-aggregation 
processes of lipid aggregates not well adhered to the mica support.  
 
4.1 Concluding remarks 
 Taken together the biochemical data as well as the flotillin-1 recognition and its high content 
in the membrane micro-domains, strongly indicate that the nanometer areas protruding from the 
membrane patch surface and visualized in AFM images are lipid rafts. Moreover, our results are in 
favourable agreement with data reported in literature and obtained using different experimental 
approaches [2, 10]. We believe that further applications of AFM imaging to lipid raft topic in both 
healthy and pathological native biological membranes coupled with a detailed biochemical 
investigation could contribute to better understanding some basic properties and molecular 
mechanisms of this important biological phenomenon. 
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FIGURE CAPTIONS 
 
Figure 1. 
Distribution of flotillin-1 in Triton X-100 isolated MDA-MB-231 human breast cancer cell membranes. 
Triton X-100 lysates of cell cultures were purified and fractionated by sucrose gradient ultracentrifugation. 
Equal volumes of each fraction were analysed by Western Blotting with antibodies to flotillin-1 protein. 
Fractions 5 and 6 have the highest flotillin-1 content. 
 
Figure 2. 
Distribution of CHOL (a) and SM (b) content in Triton X-100 isolated MDA-MB-231 human breast cancer 
cell membranes. Triton X-100 lysates of cell cultures were purified and fractionated by sucrose gradient 
ultracentrifugation. Equal volumes of each fraction were analysed by HP-TLC. Fractions 5 and 6 have the 
highest content of CHOL and SM. 
 
Figure 3. 
 AFM topography images of some isolated fractions. Purified membranes were diluted 1:30 in distilled water 
and 50 μl of the suspension placed on a mica support. AFM images were collected in liquid buffer in tapping 
mode. Different situations were visualized: membrane patches with lateral sizes of a few microns and height 
of 4 nm (fractions from 5 to 7), small membrane fragments (fractions from 1 to 4, 8 and 9) and an 
homogeneous distribution of membrane fragments on the whole support (fractions 10 and 11). For all the 
images: scan area = 10x10 μm2; z range (from darkest to lightest) = 20 nm; scale bar = 1 μm. 
 
Figure 4.  
AFM topography image of a membrane sample prepared from fraction 5 collected in liquid buffer in tapping 
mode. Different regions are visualized: the mica support (1), a membrane patch (2), two micro-domains 
protruding from the membrane surface (3) and higher aggregates (white areas).  
Scan area = 1.5x1.5 μm2; z range (from darkest to lightest) = 15 nm. 
 
Figure 5. 
(left) AFM topography image of a membrane sample prepared from fraction 5 and collected in liquid buffer 
in tapping mode. The image shows a membrane patch 4 nm thick (green arrows) with two micro-domains 
and some protein aggregates (brighter areas). (right) Height profile corresponding to the black line drawn 
in AFM image. The micro-domain protrudes by 2 nm from the membrane surface (red arrows). Scan area = 
1.6x1.6 μm2; z range (from darkest to lightest) = 20 nm.      
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Figure 6.  
(left) High resolution AFM topography image of a membrane sample prepared from fraction 5 and collected 
in liquid buffer in tapping mode. The image shows a micro-domain (1) which protrudes by about 1 nm from 
the surface (2) of the membrane patch (red arrows). The micro-domain has a surface roughness while the 
surrounding membrane is very smooth. (right) Height profile corresponding to the black line drawn in AFM 
image. Nanometer features are visible on the micro-domain surface comparable for dimensions with 
proteins. Scan area =  200x200 nm
2
; z range (from darkest to lightest) = 2 nm.     
 
Figure 7.  
AFM topography images of membrane samples prepared from fraction 5 and collected in liquid buffer in 
tapping mode. Untreated membrane patches (a) were incubated with anti flotillin-1 antibody (1:4 in 
adsorption buffer) for different times (0, 30, 60 min). Just after 60 min of treatment (b) the surface area of 
micro-domains protruding from the membrane patches clearly increases (see circled areas) thus suggesting 
the presence of flotillin-1 proteins. Scan area = 5x5 μm2;  z range (from darkest to lightest) = 25 nm.     
 
Figure 8. 
Histogram of the surface area increase for membrane patches, 7.9 ± 1.5% (mean ± SD; n = 10) 8.3 ± 2.4% 
(mean ± SD; n = 10),  and micro-domains, 17.8 ± 6.1% (mean ± SD; n = 12) 20.7 ± 5.6% (mean ± SD; n = 
11), after 60 min anti flotillin-1 antibody incubation (gray bars) and of the surface area increase for 
membrane patches, 8.8 ± 1.9% (mean ± SD; n = 10) 9.4 ± 2.5% (mean ± SD; n = 10),  and micro-domains, 
6.7 ± 1.7% (mean ± SD; n = 10) 8.1 ± 1.6% (mean ± SD; n = 10), in the control experiment after 60 min anti 
clathrin hc antibody incubation (white bars). The observed difference among the surface area increase of the 
micro-domains, induced by the anti flotillin-1 antibody treatment, and of membrane patches both in the anti 
flotillin-1 antibody treated and control experiment as well as of the micro-domains in the control experiment 
is statistically significant (t-Student’s test: P < 0.01). 
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